teprotumumab

Catherine J Hwang1, Nicole P Rebollo1, Keegan B Mechels1

  • 1From Department of Oculofacial Plastic Surgery, Cole Eye Institute, Cleveland Clinic, Cleveland, Ohio, USA.

PubMed
概括

针对甲状腺眼病的teprotumumab治疗在两年内显示出33%的持续反应率. 疾病的重新激活是常见的,导致80%的病例的亡回归,双眼视的长期改善最小.

相关概念视频

Synthesis and Regulation of Thyroid Hormones01:20

Synthesis and Regulation of Thyroid Hormones

Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
4.6K